• Explore /
  • Poster
  • / Long term toxicity and fatigue after treatment for non-Hodgkin lymphoma (NHL): An analysis of twelve collaborative lymphoma study Association (LYSA) trials, the Simonal Study.

Long term toxicity and fatigue after treatment for non-Hodgkin lymphoma (NHL): An analysis of twelve collaborative lymphoma study Association (LYSA) trials, the Simonal Study.

Abstract Poster

Authors

null

Nicolas Mounier

CHU l'Archet, Nice, France

Nicolas Mounier , Sabine Anthony , Raphael Busson , Catherine Thieblemont , Virginie Nerich , Vincent Ribrag , Marie Castera , Herve Tilly , Corinne Haioun , Rene-Olivier Casasnovas , Franck Morschhauser , Pierre Feugier , Richard Delarue , Loic Ysebaert , Catherine Sebban , Florence Broussais , Gandhi Damaj , Jean-Philippe Jais , Michel Henry-Amar , Gilles A. Salles

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

pooled trials already registred

Citation

J Clin Oncol 34, 2016 (suppl; abstr 7518)

DOI

10.1200/JCO.2016.34.15_suppl.7518

Abstract #

7518

Poster Bd #

74

Abstract Disclosures

Similar Posters

First Author: Mariano Provencio-Pulla

First Author: David Matthew Kurtz

Poster

2013 ASCO Annual Meeting

An open-label phase II study of ibrutinib in patients with refractory follicular lymphoma.

An open-label phase II study of ibrutinib in patients with refractory follicular lymphoma.

First Author: Gilles A. Salles

First Author: Laurie Helen Sehn